Neurogene Inc. NGNE
- NGN-401 — Rett Syndrome Phase 3
MECP2 (2 companies · 2 programs)
Companies with an active program directed at MECP2.
Taysha Gene Therapies, Inc. TSHA
- TSHA-102 — Rett Syndrome Phase 3
Companies with an active program directed at MECP2.